Evy Liswati, Evy
Unknown Affiliation

Published : 3 Documents
Articles

Found 3 Documents
Search

Biochemical Markers for Differential Diagnosis of Stroke: A Biochemical Markers Study of S100B Protein, Neuron Spesific Enolase (NSE), Myelin Basic Protein (MBP), and Heart-Type Fatty Acid Binding Protein (H-FABP) Liswati, Evy; Wijaya, Andi; Ranakusuma, Teguh A. S.
The Indonesian Biomedical Journal Vol 1, No 1 (2009)
Publisher : The Prodia Education and Research Institute (PERI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18585/inabj.v1i1.85

Abstract

BACKGROUND: Differential diagnosis between hemorrhagic and ischemic stroke, which determine how to treat the patients, was performed by CT-Scan. CT-Scan is not always available in all Indonesian health care facility. Other alternative using biochemical markers needed to be studied.METHODS: In total of 44 stroke patients consist of 25 ischemic and 19 hemorrhagic strokes according to CTScan, participated in this study. S100B Protein, NSE, MBP and H-FABP concentration in the blood of each stroke patient was determined.RESULTS: Among the biochemical markers used, only MBP at cut off point 0,712 ng/ml could be used for diagnosing hemorrhagic from ischemic stroke for serum samples obtained until 72 hours after onset of the stroke. If samples could be obtained within 24 hours, S100B Protein and MBP could be used for diagnosing hemorrhagic from ischemic stroke. If both markers increased (S100B Protein >7.55 pg/ml and MBP >0.109 ng/ml) sensitivity and specificity would be 77.8% and 84.6% respectively.CONCLUSIONS: MBP and S100B Protein are promising markers for differential diagnosis of hemorrhagic from ischemic stroke. Using serum samples obtained within 24 hours after onset and multiple markers (MBP and S100B Protein) will improved diagnostic performance of the test.KEYWORDS: Stroke, S100B Protein, Neuron Specific Enolase, Myelin Basic Protein, and Heart-Type Fatty Acid Binding Protein
Heart-type Fatty Acid-Binding Protein (H-FABP) sebagai Penanda Biokimiawi untuk Membedakan Stroke Iskemik dan Hemoragik Halimah, Eli; Liswati, Evy; Sasmita, Erwin
Indonesian Journal of Clinical Pharmacy Vol 6, No 1 (2017)
Publisher : Indonesian Journal of Clinical Pharmacy

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (528.552 KB) | DOI: 10.15416/ijcp.2017.6.1.55

Abstract

Stroke merupakan sindrom neurologis yang bersifat akut yang terjadi karena adanya penurunan alirandarah yang disebabkan oleh terhambat atau pecahnya pembuluh darah otak (cerebrovaskular) yangmenyebabkan kerusakan jaringan otak. Berdasarkan patogenesisnya, terdapat dua jenis stroke, yaitustroke iskemik dan hemoragik, di mana penanganan pengobatan pada kedua jenis stroke tersebut sangatberbeda sehingga diperlukan diagnosis diferensial untuk membedakan kedua jenis stroke tersebut. Tujuanpenelitian ini yaitu untuk menentukan apakah Heart-type Fatty Acid-Binding Protein (H-FABP) dapatdijadikan sebagai parameter penanda biokimiawi untuk membedakan stroke iskemik dan hemoragik.Penetapan kadar H-FABP dilakukan dengan menggunakan serum darah dan dianalisis dengan metodeEnzyme Linked Immunosorbent Assay (ELISA) sandwich masing-masing menggunakan H-FABP testkit. Serum darah diambil dari 20 orang pasien stroke iskemik dan 18 orang pasien stroke hemoragikdari Instalasi Gawat Darurat (IGD), Unit Stroke dan Instalasi Rawat Inap di salah satu Rumah SakitUmum di Jakarta. Hasil penelitian menunjukkan bahwa kadar rata-rata H-FABP pada pasien strokeiskemik sebesar 9,07 ng/mL sedangkan pasien stroke hemoragik sebesar 18,54 ng/mL; secara statistikterdapat perbedaan kadar H-FABP yang signifikan antara pasien stroke iskemik dan hemoragik (α=0,05).Dengan demikian, Heart-type Fatty Acid-Binding Protein (H-FABP) dapat dijadikan sebagai salah satuparameter penanda biokimiawi untuk membedakan stroke iskemik dan hemoragik.
Heart-type Fatty Acid-Binding Protein (H-FABP) sebagai Penanda Biokimiawi untuk Membedakan Stroke Iskemik dan Hemoragik Halimah, Eli; Liswati, Evy; Sasmita, Erwin
Indonesian Journal of Clinical Pharmacy Vol 6, No 1 (2017)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (6927.71 KB) | DOI: 10.15416/ijcp.2017.6.1.55

Abstract

Strok merupakan sindrom neurologis yang bersifat akut yang terjadi karena adanya penurunan aliran darah yang disebabkan oleh terhambat atau pecahnya pembuluh darah otak (cerebrovaskular) yang menyebabkan kerusakan jaringan otak. Berdasarkan patogenesisnya, terdapat dua jenis strok, yaitu strok iskemik dan hemoragik. Penanganan pengobatan pada kedua jenis strok tersebut sangat berbeda sehingga diperlukan diagnosis diferensial untuk membedakan kedua jenis strok tersebut. Tujuan penelitian ini yaitu untuk menentukan apakah Heart-type Fatty Acid-Binding Protein (H-FABP) dapat dijadikan sebagai parameter penanda biokimiawi untuk membedakan strok iskemik dan hemoragik. Penetapan kadar H-FABP dilakukan dengan menggunakan serum darah dan dianalisis dengan metode Enzyme Linked Immunosorbent Assay (ELISA) sandwich masing-masing menggunakan H-FABP test kit. Serum darah diambil dari 20 orang pasien strok iskemik dan 18 orang pasien strok hemoragik dari Instalasi Gawat Darurat (IGD), Unit Strok dan Instalasi Rawat Inap di salah satu Rumah Sakit Umum di Jakarta. Hasil penelitian menunjukkan bahwa kadar rata-rata H-FABP pada pasien strok iskemik sebesar 9,07 ng/mL sedangkan pasien strok hemoragik sebesar 18,54 ng/mL; secara statistik terdapat perbedaan kadar H-FABP yang signifikan antara pasien strok iskemik dan hemoragik (α=0,05). Dengan demikian, Heart-type Fatty Acid-Binding Protein (H-FABP) dapat dijadikan sebagai salah satu parameter penanda biokimiawi untuk membedakan strok iskemik dan hemoragik.Kata kunci: Heart-type Fatty Acid-Binding Protein (H-FABP), strok hemoragik, strok iskemik Heart-type Fatty Acid-Binding Protein (H-FABP) as a Biochemical Marker to Differentiate Ischemic and Hemorrhagic StrokeAbstractStroke is an acute neurological syndrome that occurs due to a decrease in blood flow caused by blocked or rupture of blood vessels of the brain (cerebrovascular) that causes damage to brain tissue. Based on the pathogenesis, there are two types of stroke, the ischemic and hemorrhagic stroke, in which the handling of treatment in both types of stroke are very different, so the differential diagnosis is required to distinguish the two types of stroke. The purpose of this study is to determine whether Heart-type Fatty Acid-Binding Protein (H-FABP) can be used as a parameter of biochemical marker to distinguish between ischemic and hemorrhagic stroke. H-FABP assay is performed using blood serum and analyzed by Enzyme Linked Immunosorbent Assay (ELISA) sandwich method, each using H-FABP test kit. Blood serum taken from 20 patients with ischemic strokes and 18 hemorrhagic stroke patients from one of a hospital in Jakarta. The results showed that the average H-FABP concentration in ischemic stroke‑patients is 9,07 ng/mL and hemorrhagic stroke‑patients is 18,54 ng/mL; statistically there are significant difference between H-FABP concentration in ischemic stroke‑patients and hemorrhagic stroke-patients (α=0.05). Thus Heart-type Fatty Acid-Binding Protein (H-FABP) can be used as one of the parameters of biochemical markers to distinguish between ischemic and hemorrhagic stroke.Keywords: Heart-type Fatty Acid-Binding Protein (H-FABP), hemorrhagic stroke, ischemic stroke